Physician profile
Justin Lee
NPI 1649716259
$4,389.97
in general payments reported to CMS, 2019-2025
10 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $268 · 2020: $350 · 2022: $2,503 · 2023: $751 · 2024: $361 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,268.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $2,347.78 | 2022 | |
| Medical Device Business Services, INC. | $617.93 | 2019-2020 | |
| Medtronic, INC. | $461.00 | 2022-2024 | Mazor X System, Unid_pass, O-Arm |
| Providence Medical Technology, INC. | $328.09 | 2023-2025 | |
| Stryker Corporation | $301.23 | 2022-2025 | Yukon Oct Spinal System, Everest Spinal System, Cascadia Interbody System |
| Si-Bone, INC. | $171.30 | 2023 | |
| Vb Spine LLC | $99.07 | 2025 | Monterey Al |
| Depuy Synthes Sales INC. | $28.22 | 2024 | Symphony |
| Zimvie INC. | $19.81 | 2023 | |
| Progenics Pharmaceuticals, INC. | $15.54 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.